Oncology Nursing News®

Adverse Event Management

Helping Patients with Lung Cancer Understand Their Treatment Options

Helping Patients with Lung Cancer Understand Their Treatment Options

BY CONOR KILLMURRAY

Oncology Nurses Provide Patients an Avenue to Supportive Care

Oncology Nurses Provide Patients an Avenue to Supportive Care

BY DIANA MARTINS-WELCH, MD

Pegfilgrastim Biosimilar Approved By FDA

Pegfilgrastim Biosimilar Approved By FDA

BY GINA COLUMBUS

Addressing the Unmet Needs of Patients with Hairy Cell Leukemia

Addressing the Unmet Needs of Patients with Hairy Cell Leukemia

BY KERRY ROGERS, MD

Eflapegrastim BLA Resubmitted to FDA For Management of Chemo-Induced Neutropenia

Eflapegrastim BLA Resubmitted to FDA For Management of Chemo-Induced Neutropenia

BY GINA COLUMBUS

Expert Discusses the Safety of Vemurafenib

Expert Discusses the Safety of Vemurafenib

BY AGNIESZKA JANUS, MD, PHD

Managing Toxicities Of Moxetumomab Pasudotox

Managing Toxicities Of Moxetumomab Pasudotox

BY ROBERT J. KREITMAN, MD

FDA Recommends New Labeling Guidelines For Breast Implants

FDA Recommends New Labeling Guidelines For Breast Implants

BY CONOR KILLMURRAY

Childhood Neuroblastoma Survivors at Risk for Cognitive Impairment

Childhood Neuroblastoma Survivors at Risk for Cognitive Impairment

BY BRIELLE BENYON

What Are the Needs of Cancer Survivors 5 Years or More After Treatment?

What Are the Needs of Cancer Survivors 5 Years or More After Treatment?

BY VICTORIA PUZO, LCSW, MSW

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.